HERCULES, Calif.--(BUSINESS WIRE)--
Bio-Rad Laboratories, Inc. (NYSE:BIO and BIOb), a
global leader of life science research and clinical diagnostic
products, today announced that Norman Schwartz, President and CEO,
and Ilan Daskal, Executive Vice President and CFO, will participate
in Jefferies 2019 Global Healthcare Conference on Tuesday, June 4,
at 10 AM (Eastern Time), in New York, NY.
A link to the live webcast of the presentation
will be available in the Investor Relations area of our website at
Bio-Rad Laboratories, Inc. (NYSE:BIO and BIOb) is
a global leader in developing, manufacturing, and marketing a broad
range of innovative products for the life science research and
clinical diagnostic markets. With a focus on quality and customer
service for over 65 years, our products advance the discovery
process and improve healthcare. Our customers are university and
research institutions, hospitals, public health and commercial
laboratories, biotechnology, pharmaceutical, as well as applied
laboratories that include food safety and environmental quality.
Founded in 1952, Bio-Rad is based in Hercules, California, and has
a global network of operations with more than 8,000 employees
worldwide. Bio-Rad had revenues exceeding $2.2 billion in 2018. For
more information, please visit www.bio-rad.com.
View source version on